B Mikkelsen, E Birket-Smith. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdolescentAdultAnticonvulsants/administration & dosageAnticonvulsants/adverse effectsAnticonvulsants/therapeutic useBenzodiazepinones/administration & dosageBenzodiazepinones/adverse effectsBenzodiazepinones/therapeutic useChlorobenzenes/administration & dosageChlorobenzenes/adverse effectsChlorobenzenes/therapeutic useDrug EvaluationDrug Therapy, CombinationElectroencephalographyEpilepsy/drug therapyEpilepsy, Temporal Lobe/drug therapyEpilepsy, Tonic-Clonic/drug therapyFatigue/chemically inducedFemaleHumansMaleMiddle AgedNitro Compounds/administration & dosageNitro Compounds/adverse effectsNitro Compounds/therapeutic useTime Factors
Substances： See more » AnticonvulsantsBenzodiazepinonesChlorobenzenesNitro Compounds
Year: 1973 PMID： 4202699 DOI： 10.1111/j.1600-0404.1973.tb02290.x
Source DB: PubMed Journal: Acta Neurol Scand Suppl ISSN： 0065-1427